BEUDAMED
    13 results · 16ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Classification: FDA Class 2 ×

    Radiology Software For Opportunistic Evaluation Of Low Bone Mineral Density

    FDA classification
    FDA Class 2 ·Radiology Software For Opportunistic Evaluation Of Low Bone Mineral Density

    TOTIM Patient Cushion Immobilization System

    FDA 510(k)
    FDA Class 2 ·Radiology

    S & W MODEL ASO

    FDA 510(k)
    FDA Class 2 ·Obstetrics/Gynecology

    WIELAND ZENO CAO TEMPORARY PMMA DISC, TOOTH-COLORED

    FDA 510(k)
    FDA Class 2 ·Dental

    Igm (Mu Chain Specific), Antigen, Antiserum, Control

    FDA classification
    FDA Class 2 ·Igm (Mu Chain Specific), Antigen, Antiserum, Control

    Airway, Esophageal (Obturator)

    FDA classification
    FDA Class 2 ·Airway, Esophageal (Obturator)

    Sars-Cov-2 Serology Test

    FDA classification
    FDA Class 2 ·Sars-Cov-2 Serology Test

    Non-Sars Coronavirus Multiplex Nucleic Acid Assay

    FDA classification
    FDA Class 2 ·Non-Sars Coronavirus Multiplex Nucleic Acid Assay

    Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

    FDA classification
    FDA Class 2 ·Respiratory Specimen Nucleic Acid Sars-Cov-2 Test

    Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    FDA classification
    FDA Class 2 ·Over-The-Counter Molecular Test To Detect Sars-Cov-2 From Clinical Specimens

    Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    FDA classification
    FDA Class 2 ·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings